Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
186
-
Total 13F shares, excl. options
-
170M
-
Shares change
-
+5.59M
-
Total reported value, excl. options
-
$610M
-
Value change
-
+$19.9M
-
Put/Call ratio
-
0.52
-
Number of buys
-
108
-
Number of sells
-
-59
-
Price
-
$3.58
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q3 2023
204 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q3 2023.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 186 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 170M shares
of 237M outstanding shares and own 71.92% of the company stock.
Largest 10 shareholders include BlackRock Inc. (16.7M shares), VANGUARD GROUP INC (12.8M shares), Nuveen Asset Management, LLC (10.7M shares), STATE STREET CORP (9.6M shares), Stonepine Capital Management, LLC (9.1M shares), D. E. Shaw & Co., Inc. (7.57M shares), PERCEPTIVE ADVISORS LLC (6.98M shares), AWM Investment Company, Inc. (6M shares), Magnetar Financial LLC (5.87M shares), and Invesco Ltd. (5.42M shares).
This table shows the top 186 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.